PANTHERx® Rare Partners with Rhythm Pharmaceuticals for IMCIVREE® Distribution PANTHERx® Rare has been appointed as the exclusive U.S. specialty pharmacy for IMCIVREE®, expanding its commitment to support rare disease care.

PANTHERx® Rare Partners with Rhythm Pharmaceuticals for IMCIVREE® Distribution #United_States #Pittsburgh #PANTHERx #Rhythm_Pharmaceuticals #IMCIVREE

As a patient who's living with a rare genetic condition (hypophosphatasia) and is a beneficiary of such innovations & support #Alexion Pharmaceuticals #PANTHERx Rare Pharmacy, these shared experiences and goals are a constant reminder that life is precious and each new day brings hope for progress.

PANTHERx® Reveals Insights on Rare Disease Care Coordination Ahead of Rare Disease Day On the brink of Rare Disease Day, PANTHERx® publishes vital research shedding light on care coordination challenges faced by patients with rare diseases.

PANTHERx® Reveals Insights on Rare Disease Care Coordination Ahead of Rare Disease Day #USA #Pittsburgh #PANTHERx #Rare_Disease #Care_Coordination

PANTHERx® Rare Selected for Distribution of Crenessity™ by Neurocrine Biosciences, Transforming CAH Treatment Neurocrine Biosciences has chosen PANTHERx® Rare for distributing Crenessity™, an innovative treatment for congenital adrenal hyperplasia affecting many lives.

PANTHERx® Rare Selected for Distribution of Crenessity™ by Neurocrine Biosciences, Transforming CAH Treatment #United_States #Pittsburgh #PANTHERx #Crenessity #Neurocrine

PANTHERx® Rare Teams Up with Ascendis Pharma for YORVIPATH® Distribution PANTHERx® Rare partners with Ascendis Pharma to distribute YORVIPATH®, a treatment for hypoparathyroidism, providing vital support for patients nationwide.

PANTHERx® Rare Teams Up with Ascendis Pharma for YORVIPATH® Distribution #United_States #Pittsburgh #YORVIPATH® #Ascendis_Pharma #PANTHERx